BRIEF published on 04/30/2026 at 19:21, 4 months 11 days ago AXA Shareholders Approve Key Resolutions at Annual Meeting Board Composition Dividend Approval Financial Resolutions AXA Shareholders' Meeting CEO Mandate Renewal
BRIEF published on 04/30/2026 at 19:21, 4 months 11 days ago Approbations et renouvellements lors de l'Assemblée Générale d'AXA AXA Assemblée Générale Dividende Thomas Buberl Philomena Colatrella
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago DOUGLAS Group Sales Growth in Q2 But Adjusted EBITDA Outlook Revised Market Challenges Sales Growth EBITDA Guidance Strategic Focus Impairments
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago Croissance des ventes du groupe DOUGLAS au deuxième trimestre, mais révision des perspectives d'EBITDA ajusté Croissance Des Ventes Défis Du Marché Orientation Stratégique Prévisions D'EBITDA Déficiences
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago BioVersys Announces Successful AGM Approvals Leadership Changes Shareholders' Support BioVersys AGM Antibacterial Development Board Approvals
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago BioVersys annonce avoir obtenu les approbations nécessaires lors de son assemblée générale annuelle. Soutien Des Actionnaires Assemblée Générale Annuelle De BioVersys Développement Antibactérien Changements De Leadership Approbations Du Conseil D'administration
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago Caldwell Strengthens Technology Practice with New Co-Leader Digital Transformation Executive Search Technology Leadership AI And Innovation Shawn Banerji
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago Caldwell renforce son pôle technologique avec un nouveau co-responsable Transformation Numérique Leadership Technologique Recrutement De Cadres IA Et Innovation Shawn Banerji
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago Recticel Increases Capital through Subscription Rights Exercise Capital Increase Euronext Brussels Subscription Rights Recticel Group Insulation Solutions
BRIEF published on 04/30/2026 at 19:05, 4 months 11 days ago Recticel augmente son capital par le biais d'une augmentation de capital souscrite Augmentation De Capital Euronext Bruxelles Solutions D'isolation Droits D'abonnement Groupe Recticel
Published on 09/12/2026 at 02:35, 41 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 4 hours 16 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 5 hours 11 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 5 hours 51 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 10 hours 16 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 5 hours 1 minute ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 5 hours 5 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 7 hours 31 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 9 hours ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 20 hours 16 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 7 hours ago Availability of the 2026 Interim Financial Report
